INFLUENCE OF COUMARIN TREATMENT ON PATENCY AND LIMB SALVAGE AFTER PERIPHERAL ARTERIAL RECONSTRUCTIVE SURGERY

被引:58
作者
ARFVIDSSON, B [1 ]
LUNDGREN, F [1 ]
DROTT, C [1 ]
SCHERSTEN, T [1 ]
LUNDHOLM, K [1 ]
机构
[1] GOTHENBURG UNIV,SAHLGRENS HOSP,DEPT SURG,S-41345 GOTHENBURG,SWEDEN
关键词
D O I
10.1016/S0002-9610(06)80065-6
中图分类号
R61 [外科手术学];
学科分类号
摘要
The effect of coumarin on patency, limb salvage, and survival after primary femoro-popliteal and femoro-distal reconstructions was studied in 116 randomized patients (61 in the study group and 55 in the control group). All patients were treated postoperatively with heparin. Patients allocated to the study group received dicumarol (a coumarin derivative) orally postoperatively. The overall patency after 1 year was 75±6%, compared with 74±6%, after 2 years 65±9 compared with 57±8%, and after 3 years 46±11% compared with 42±9% (means ± SE) in the study and control groups, respectively. There were no statistically significant differences in limb salvage or survival rates between the two groups. In contrast, coumarin treatment was associated with serious bleeding complications in 4% to 5% of the study patients. As expected, limb salvage was lower in patients with critical ischemia (p<0.03), and this was also true for survival (p<0.04), which was also influenced by the level of the reconstruction; survival was lower in patients with femoro-distal reconstructions (p<0.001). Our results demonstrate that coumarin treatment does not improve outcome in routine femoro-popliteal and femoro-distal reconstructive surgery. © 1990, Reed Publishing USA. All rights reserved.
引用
收藏
页码:556 / 560
页数:5
相关论文
共 16 条
[1]  
[Anonymous], 1956, NONPARAMETRIC STAT B
[2]  
Bergqvist D, 1985, Acta Chir Scand Suppl, V529, P107
[3]  
Cox DR, 1984, ANAL SURVIVAL DATA, pviii
[4]  
FRIEDMAN LM, 1983, FUNDAMENTALS CLIN TR, P156
[5]   LONG-TERM RESULTS OF AUTOGENOUS VEIN BYPASS GRAFTS IN FEMOROPOPLITEAL ARTERIAL-OCCLUSION [J].
GRIMLEY, RP ;
OBEID, ML ;
ASHTON, F ;
SLANEY, G .
BRITISH JOURNAL OF SURGERY, 1979, 66 (10) :723-726
[6]   SAMPLE SIZES FOR MEDICAL TRIALS WITH SPECIAL REFERENCE TO LONG-TERM THERAPY [J].
HALPERIN, M ;
ROGOT, E ;
GURIAN, J ;
EDERER, F .
JOURNAL OF CHRONIC DISEASES, 1968, 21 (01) :13-&
[7]  
HILL AB, 1971, PRINCIPLES MED STATI, P254
[8]   INFLUENCE OF ANTICOAGULANT TREATMENT IN PREVENTING GRAFT OCCLUSION FOLLOWING SAPHENOUS-VEIN BYPASS FOR FEMOROPOPLITEAL OCCLUSIVE DISEASE [J].
KRETSCHMER, G ;
WENZL, E ;
WAGNER, O ;
POLTERAUER, P ;
EHRINGER, H ;
MINAR, E ;
SCHEMPER, M .
BRITISH JOURNAL OF SURGERY, 1986, 73 (09) :689-692
[9]  
SAGGAU W, 1975, J CARDIOVASC SURG, V16, P386
[10]   FACTORS DETERMINING OUTCOME OF REVERSED SAPHENOUS-VEIN FEMORO-POPLITEAL BYPASS GRAFTS [J].
SONNENFELD, T ;
CRONESTRAND, R .
BRITISH JOURNAL OF SURGERY, 1980, 67 (09) :642-648